Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
===========================================================================================================================================================================================

* Joseph Broucek
* Tasha Hughes
* Erica Huelsmann
* Eugene Lusciks
* Graham Hill
* Janet Zayas
* Joseph Poshepny
* Carl Ruby
* Frederick Kohlhapp
* Andrew Zloza
* Howard Kaufman